AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Mar 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-03-12

Reporting Person: Do Hung (Sr Vice President Discovery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-12	Common stock	D	85032	$2.21	Disposed	1016669	Direct
2014-03-14	Common stock	D	22065	$2.26	Disposed	994604	Direct

Footnotes

F1: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $2.115 to $2.245. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $2.24 to $2.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.